Using a high-grade endometrial carcinoma patient cohort, NaroNet found, among other TMEs that could be explored, a local phenotype expressing CD8, PD1, and FOXP3 whose high abundance was associated with the POLE mutation, while achieving a prediction accuracy of 93.75%. This evidence concerns the gene CD8A and endometrial carcinoma.